A recent report showed that AhR and its activating enzymes, IDO1 and tryptophan 2,3- dioxygenase (TDO), were highly expressed in diffuse large B-cell lymphoma (DLBCL) patient samples and were inversely correlated with patient survival (23). The gene discussed is IDO1; the disease is diffuse large B-cell lymphoma.